New York University Medical Center
530 First Avenue, Suite 9V
New York, New York 10016
Email Address: Harvey.email@example.com
Dr. Harvey I. Pass is Director of the Division of Thoracic Surgery at New York University Medical Center in New York, New York. He is also Chief of Thoracic Oncology at New York University Medical Center. In addition to mesothelioma, Dr. Pass’s clinical expertise is in the areas of thoracic oncology, translational research, clinical trials, and lung cancer.
Dr. Pass attended Johns Hopkins University from 1967-1970. He attended Duke University Medical School, in Durham, North Carolina, from 1970-1973 where he received his Medical Degree (M.D.). He completed his Surgical Residency at Duke University from 1974-1975. He was Senior and Chief Surgeon at the University of Mississippi Medical Center, Division of Surgery, from 1977-1980. From 1980-1982, he completed his Senior Residency and he was Chief Resident at the Medical University of South Carolina, Division of Cardiothoracic Surgery.
Dr. Pass completed his 3-year Senior Fellowship in the Thoracic Oncology Surgical Branch of the National Cancer Institute (NCI). He was appointed Head of Thoracic Oncology for the National Cancer Institute in 1986. He held the position for the next 10 years. During this time Dr. Pass published the first three editions ofLung Cancer: Principles and Practice – a reference text, and he was awarded the National Institutes of Health (NIH) Directors Award in 1991 for his contributions to thoracic oncology. In 1996, Dr. Pass began building the thoracic oncology program at Karmanos Cancer Institute of Wayne State University in Detroit, Michigan.
During his time at Karmanos Cancer Institute of Wayne State University in Detroit, Michigan, from 1996-2005, the Department of Veterans Affairs Merit awards continually funded Dr. Pass, and the Early Detection Research Network of the National Cancer Institute (NCI) also funded him. He helped found theMesothelioma Applied Research Foundation (MARF) in 1998, and he started the first low-dose helical screening program for lung cancer in Michigan. Dr. Pass received his Board Certification in Thoracic Surgery in 2001 and he was awarded Detroit’s Top Doctors award in 2004 and 2005.
The New York University School of Medicine, Division of Thoracic Surgery, recruited Dr. Pass in 2005 to become the first Director of the New York University Division of Thoracic Surgery. Today, Dr. Pass serves as a Lung Cancer Alliance Board member and Chairman of the Scientific Advisory Board for the Mesothelioma Applied Research Foundation. In addition, Dr. Pass has been awarded Castle Connolly’s America’s Top Doctors award for the last five years.